Visine Classic Hydro 0,5 mg/ml, Augentropfen

7680682930012 CH-68293 Augentropfen
Visine Classic Hydro 0,5 mg/ml, Augentropfen
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
15
Selling units
15
Measure
ml
Galenic form
Augentropfen
Galenic group
Augenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/04/2025
Patient information leaflet
Français
29/04/2025
Patient information leaflet
Italien
29/04/2025
Summary of Product Characteristics
Allemand
29/04/2025
Summary of Product Characteristics
Français
29/04/2025
Summary of Product Characteristics
Italien
29/04/2025

Detailed composition

Substance Quantity Type Category
tetryzolini hydrochloridum
0.5 MG Substance Wirkstoff (Principe actif)
glycerolum
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
acidum boricum
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
phosphas
0.179 MG Substance HBESI
natrii citras dihydricus
- Substance HNIDK
kalii chloridum
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
natrii (S)-lactas
- Substance HNIDK
glycinum
- Substance HNIDK
acidum ascorbicum
- Substance HNIDK
glucosum monohydricum
- Substance HNIDK
polyquaternium-42
- Substance HNIDK
aqua purificata
- Substance HNIDK

Authorization holder

JNTL Consumer Health II

6343 Risch

Authorization information

Swissmedic authorization number
68293
Drug name
Visine Classic Hydro, Augentropfen
Galenic form
AUL
ATC Code
S01GA02
Authorization status
Z
Dispensing category
D
First authorization
02/05/2022
Authorization expiration date
01/05/2027
IT Number
11.04.0.
Domain
Human medicine
Field of application
Konjunktivale Irritationen

Package details

Description (FR)
VISINE Classic Hydro gtt opht 0.5 mg/ml fl 15 ml
Description (DE)
VISINE Classic Hydro Gtt Opht 0.5 mg/ml Fl 15 ml
Market launch
02/05/2022
Narcotic (BTM)
No
Buy us a coffee Explore the data